LSL — LSL Pharma Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual balance sheet for LSL Pharma, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.

	R2011 July 31st	2012 July 31st	2021 July 31st	2022 July 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	Interim Report	ARS	ARS	ARS	ARS
Standards:	CAS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Cash and Short Term Investments	0.183	0.117	0	0	0.008
Net Total Accounts Receivable
Net Total Receivables	0.02	0.091	0.017	0.025	2.68
Total Inventory
Prepaid Expenses
Total Current Assets	0.217	0.21	0.017	0.026	7.2
Net Property, Plant And Equipment	—	0.002	—	—	14.7
Net Intangible Assets
Other Long Term Assets
Total Assets	0.217	1.16	0.017	0.026	30.9
Payable / Accrued
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	0.038	0.08	0.203	0.285	15.1
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Liabilities	0.038	0.08	0.203	0.285	22.2
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	0.178	1.08	-0.186	-0.26	8.65
Total Liabilities & Shareholders' Equity	0.217	1.16	0.017	0.026	30.9
Total Common Shares Outstanding